Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Tilles

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Allergy and Clinical Immunology|October 12, 2022
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trialJonathan Corren, David Larson, Matthew C Altman, et al.
Eclinicalmedicine|June 14, 2019
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued <i>vs</i> Discontinued Dosing in Multifood Allergic IndividualsSandra Andorf, Natasha Purington, Divya Kumar, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2019
Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ WorkshopLisa M Wheatley, Robert Wood, Kari Nadeau, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2015
Practice parameter for the diagnosis and management of primary immunodeficiencyFrancisco A Bonilla, David A Khan, Zuhair K Ballas, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2010
The diagnosis and management of anaphylaxis practice parameter: 2010 updatePhillip Lieberman, Richard A Nicklas, John Oppenheimer, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2024
Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consentDouglas P Mack, Timothy E Dribin, Paul J Turner, et al.
The New England Journal of Medicine|November 20, 2018
AR101 Oral Immunotherapy for Peanut Allergy, Brian P Vickery, Andrea Vereda, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Allergy and Clinical Immunology|October 12, 2022
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trialJonathan Corren, David Larson, Matthew C Altman, et al.
Eclinicalmedicine|June 14, 2019
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued <i>vs</i> Discontinued Dosing in Multifood Allergic IndividualsSandra Andorf, Natasha Purington, Divya Kumar, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2019
Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ WorkshopLisa M Wheatley, Robert Wood, Kari Nadeau, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2015
Practice parameter for the diagnosis and management of primary immunodeficiencyFrancisco A Bonilla, David A Khan, Zuhair K Ballas, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2010
The diagnosis and management of anaphylaxis practice parameter: 2010 updatePhillip Lieberman, Richard A Nicklas, John Oppenheimer, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2024
Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consentDouglas P Mack, Timothy E Dribin, Paul J Turner, et al.
The New England Journal of Medicine|November 20, 2018
AR101 Oral Immunotherapy for Peanut Allergy, Brian P Vickery, Andrea Vereda, et al.
Pageof 3